Emotion and ocular responses in Parkinson's disease

Neuropsychologia

Volumn 49, Issue 12, 2011, Pages 3247-3253

  Dietz, J ^a   Bradley, M M ^a   Okun, M S ^a   Bowers, D ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Arousal; Emotion; Eye movement; Parkinson's disease; Pupil

Indexed keywords

LEVODOPA; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR;

ADRENERGIC STIMULATION; ADULT; AFFECT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EMOTIONALITY; EYE FIXATION; EYE MOVEMENT; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PUPIL REFLEX; SYMPATHETIC NERVE; VISUAL DISCRIMINATION; VISUAL STIMULATION; VISUAL SYSTEM FUNCTION; VISUOMOTOR COORDINATION;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; AROUSAL; EMOTIONS; EYE MOVEMENTS; HUMANS; MIDDLE AGED; PARKINSON DISEASE; PHOTIC STIMULATION; PSYCHOPHYSIOLOGIC DISORDERS; PUPIL;

EID: 80053615937     PISSN: 00283932     EISSN: 18733514     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2011.07.029     Document Type: Article

References (54)

1. Alexander G., DeLong M., Strick P. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annual Review of Neuroscience 1986, 9:357-381.
2. Ariatti A., Benuzzi F., Nichelli P. Recognition of emotions from visual and prosodic cues in Parkinson's disease. Neurological Sciences 2008, 29(4):219-227.
3. Bartels A.L., Leenders K.L. Parkinson's disease: The syndrome, the pathogenesis and pathophysiology. Cortex: A Journal Devoted to the Study of the Nervous System and Behavior 2009, 45(8):915-921.
4. Beck A.T., Steer R.A., Brown G.K. Manual for the beck depression inventory-II 1996, Psychological Corporation, San Antonio, TX.
5. Beaumont S.M., Harris J.P., Leendertz J.A., Phillipson O.T. The pupillary light reflex in mild Parkinson's disease. Clinical Vision Sciences 1987, 2:123-129.
6. Bowers D., Kirsch-Darrow L., Mikos A., Springer U.S., Fernandez H.H., Okun M.S. Apathy and psychophysiologic blunting in Parkinson disease. Paper presented at the American academy of neurology 2008, Chicago.
7. Bowers D., Miller K., Bosch W., Gokcay D., Pedraza O., Springer U., et al. Faces of emotion in Parkinsons disease: Micro-expressivity and bradykinesia during voluntary facial expressions. Journal of the International Neuropsychological Society 2006, 12(6):765-773.
8. Bowers D., Miller K., Mikos A., Kirsch-Darrow L., Springer U., Fernandez H., et al. Startling facts about emotion in Parkinson's disease: Blunted reactivity to aversive stimuli. Brain: A Journal of Neurology 2006, 129(12):3356-3365.
9. Braak H., Braak E., Yilmazer D., de Vos R.A.I., Jansen Steur E.N.H., Bohl J., et al. Amygdala pathology in Parkinson's disease. Acta Neuropathology 1994, 88:493-500.
10. Bradley M.M., Houbova P., Miccoli L., Costa V.D., Lang P.J. Scan patterns when viewing natural scenes: Emotion, complexity, and repetition. Psychophysiology 2010.
11. Bradley M.M., Lang P.J. Measuring emotion: The self-assessment Manikin and the semantic differential. Journal of Behavior Therapy and Experimental Psychiatry 1994, 25:49-59.
12. Bradley M.M., Miccoli L., Escrig M.A., Lang P.J. The pupil as a measure of emotional arousal and autonomic activation. Psychophysiology 2008, 45:602-607.
13. Briand K.A., Strallow D., Hening W., Poizner H., Sereno A.B. Control of voluntary and reflexive saccades in Parkinson's disease. Experimental Brain Research 1999, 129:38-48.
14. Brown R., Pluck G. Negative symptoms: The 'pathology' of motivation and goal-directed behaviour. Trends in Neurosciences 2000, 23(9):412-417.
15. Clark U.S., Neargarder S., Cronin-Golomb A. Visual exploration of emotional facial expressions in Parkinson's disease. Neuropsychologia 2010, 48(7):1901-1913.
16. Cools R. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease. Neuroscience Biobehaviour Review 2006, 30:1-23.
17. Dabby R., Djaldetti R., Shahmurov M., Treves T.A., Gabai B., Melamed E., et al. Skin biopsy for assessment of autonomic denervation in Parkinson's disease. Journal of Neural Transmission 2006, 113(9):1169-1176.
18. Delaveau P., Salgado-Pineda P., Witjas T., Micallef-Roll J., Fakra E., Azulay J., et al. Dopaminergic modulation of amygdala activity during emotion recognition in patients with Parkinson disease. Journal of Clinical Psychopharmacology 2009, 29(6):548-554.
19. Fahn S., Elton R.L., Committee M.o.t.U.D Unified Parkinson's disease rating scale. Recent developments in Parkinson's disease 1987, 153-163. Macmillan Health Care Information, Florham Park. S. Fahn, C.D. Marsden, D.B. Calne, M. Goldstein, D.B. Clane (Eds.).
20. Fielding J., Georgiou-Karistianis N., White O. The role of the basal ganglia in the control of automatic visuospatial attention. Journal of the International Neuropsychological Society 2006, 12(5):657-667.
21. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975, 12:189-198.
22. Gilzenrat M.S., Nieuwenhuis S., Jepma M., Cohen J.D. Pupil diameter tracks changes in control state predicted by the adaptive gain theory of locus coeruleus function. Cognitive, Affective and Behavioral Neuroscience 2010, 10(2):252-269.
23. Granholm E., Morris S., Galasko D., Shults C., Rogers E., Vukov B. Tropicamide effects on pupil size and pupillary light reflexes in Alzheimer's and Parkinson's disease. International Journal of Psychophysiology 2003, 47(2):95-115.
24. Harding A., Stimson E., Henderson J., Halliday G. Clinical correlates of selective pathology in the amygdala of patients with Parkinson's disease. Brain: A Journal of Neurology 2002, 125(11):2431-2445.
25. Harris J.P. The pupil in Parkinson's disease. Journal of Psychophysiology 1991, 5:251-254.
26. Hess E.H., Polt J.M. Pupil size as related to interest value of visual stimuli. Science 1960, 132:349-350.
27. Hoehn M.M., Yahr M.D. Parkinsonism: Onset, progression and mortality. Neurology. 1967, 17:427-442.
28. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease. A clinico-pathological study of 100 cases. JNNP 1992, 55:181-184.
29. Isella V., Melzi P., Grimaldi M., Iurlaro S., Piolti R., et al. Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease. Movement Disorders 2002, 17:366-371.
30. Jordan L., Ferencz B., McKently M., Okun M.S., Bowers D. Anhedonic deficits in Parkinson's patients with apathy. Oral presentation at the annual meeting of the American Neuropsychiatric Association, March 2010.
31. Kirsch-Darrow L., Fernandez H.H., Marsiske M., Okun M.S., Bowers D. Dissociating apathy and depression in Parkinson disease. Neurology 2006, 67:33-38.
32. Lang, P.J., Bradley, M.M., Cuthbert, B.N. (2008). International affective picture system (IAPS): Affective ratings of pictures and instruction manual. Technical Report A-8. University of Florida, Gainesville, FL.
33. Leentjens A.F.G., Verhey F.R.J., Luijckx G-J., Troost J. The validity of the Beck depression inventory as a screening and diagnostic instrument for depression in patients with Parkinson's disease. Movement Disorders 2000, 15:1221-1224.
34. Levy R., Czernecki V. Apathy and the basal ganglia. Journal of Neurology 2006, 253(Suppl. 7):54-61.
35. Levy R., Dubois B. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cerebral Cortex 2006, 16:916-928.
36. Lowenstein O. Pupillary reflex shapes and topical clinical diagnosis. Neurology 1955, 5:631-644.
37. Micieli G., Tassorelli C., Martignoni E., Pacchetti C., Bruggi P., Magri M., et al. Disordered pupil reactivity in Parkinson's disease. Clinical Autonomic Research 1991, 1(1):55-58.
38. Miller K.M., Okun M.S., Marsiske M., Fennell E.B., Bowers D. Startle reflex hyporeactivity in Parkinson's disease: An emotion-specific or arousal-modulated deficit?. Neuropsychologia 2009, 47:1917-1927.
39. Phillips M., Bitsios P., Szabadi E., Bradshaw C. Comparison of the antidepressant reboxetine, fluvoxamine and amitriptyline upon spontaneous pupillary fluctuations in healthy human volunteers. Psychopharmacology 2000, 149(1):72-76.
40. Pluck G.C., Brown R.G. Apathy in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry 2002, 73:636-642.
41. Ranson S.W., Clark S.L. The anatomy of the nervous system: Its development and function 1959, W.B. Saunders, Philadelphia.
42. Rowe G., Hirsh J., Anderson A., Smith E. Positive affect increases the breadth of attentional selection. PNAS Proceedings of the National Academy of Sciences of the United States of America 2007, 104(1):383-388.
43. Schneider J. Behavioral persistence deficit in Parkinson's disease patients. European Journal of Neurology 2007, 14(3):300-304.
44. Siepmann T., Ziemssen T., Mueck-Weymann M., Kirch W., Siepmann M. The effects of venlafaxine on autonomic functions in healthy volunteers. Journal of Clinical Psychopharmacology 2007, 27(6):687-691.
45. Sockeel P., Dujardin K., Devos D., Denève C., Destée A., Defebvre L. The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: Validation in Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry 2006, 77:579-584.
46. Sprengelmeyer R., Young A.W., Mahn K., Schroeder U., Woitalla D., Büttner T., et al. Facial expression recognition in people with medicated and unmedicated Parkinson's disease. Neuropsychologia 2003, 41(8):1047-1057.
47. Starkstein S.E., Mayberg H.S., Preziosi T.J., Andrezejewski P., Leiguarda R., Robinson R.G. Reliability, validity, and clinical correlates of apathy in Parkinson's disease. Journal of Neuropsychiatry and Clinical Neuroscience 1992, 4:134-139.
48. Steinhauer S., Condray R., Kasparek A. Cognitive modulation of midbrain function: Task-induced reduction of the pupillary light reflex. International Journal of Psychophysiology 2000, 39(1):21-30.
49. Steinhauer S., Siegle G., Condray R., Pless M. Sympathetic and parasympathetic innervation of pupillary dilation during sustained processing. International Journal of Psychophysiology 2004, 52(1):77-86.
50. Taylor A.E., Saint-Cyr J.A. The neuropsychology of Parkinson's disease. Brain and Cognition 1995, 28:281-296.
51. Tessitore A., Hariri A., Fera F., Smith W., Chase T., Hyde T., et al. Dopamine modulates the response of the human amygdala: A study in Parkinson's disease. The Journal of Neuroscience 2002, 22(20):9099-9103.
52. van Koningsbruggen M.G., Pender T., Machado L., Rafal R.D. Impaired control of the oculomotor reflexes in Parkinson's disease. Neuropsychologia 2009, 47(13):2909-2915.
53. White T., Depue R. Differential association of traits of fear and anxiety with norepinephrine- and dark-induced pupil reactivity. Journal of Personality and Social Psychology 1999, 77(4):863-877.
54. Yoshida H., Yamada T., Matsuzaki H. Refelxive and volunatry saccades in Parkinson's disease. Nippon Ganka Gakkai Zasshi 2002, 106(5):281.